60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTPW) Sees Large Increase in Short Interest

60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTPW) was the recipient of a large increase in short interest in August. As of August 31st, there was short interest totaling 1,930 shares, an increase of 130.0% from the August 15th total of 839 shares. Based on an average daily volume of 4,166 shares, the short-interest ratio is presently 0.5 days.

60 Degrees Pharmaceuticals Price Performance

Shares of SXTPW remained flat at $0.04 during mid-day trading on Tuesday. The stock had a trading volume of 101 shares, compared to its average volume of 9,711. The company has a 50-day moving average price of $0.03 and a two-hundred day moving average price of $0.04. 60 Degrees Pharmaceuticals has a one year low of $0.02 and a one year high of $0.15.

About 60 Degrees Pharmaceuticals

60 Degrees Pharmaceuticals, Inc operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue.